Fight Aging! Newsletter, June 27th 2016
In conclusion, we showed for the first time that 7-KC induces oxidative stress via lysosomal dysfunction, resulting in exacerbation of calcification.
CHIMERIC ANTIGEN RECEPTOR CANCER THERAPIES CAN NOW TARGET SOLID TUMORS
https://www.fightaging.org/archives/2016/06/chimeric-antigen-receptor-cancer-therapies-can-now-target-solid-tumors/
If the research community is to win in the fight to cure cancer, and win soon enough to matter for all of us, then the focus must be on technology platforms that can be easily and cheaply adapted to many different types of cancer. The biggest strategic problem in the field is that most of the expensive, time-consuming efforts to develop new therapies are only applicable to one or a few of the hundreds of types of cancer. Immunotherapies based on the use of chimeric antigen receptors are an incremental step towards solving this problem, an improvement on the present situation because this technology may cut the cost of tailoring an immunotherapy to each specific type of cancer. This approach has worked very well in trials targeting leukemia, but there was some question as to how to adapt it for use in solid tumors, and whether it would work in this context. Fortunately, it seems that this next step forward has now been accomplished, at least in a preliminary animal study:
Chimeric antigen receptor (CAR) T cell therapy, which edits a cancer patient's T cells to recognize their tumors, has successfully helped patients with a...
Source: Fight Aging! - Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
More News: Academia | Alzheimer's | Atrial Fibrillation | Biochemistry | Biomedical Science | Biotechnology | Brain | Brain Cancers | Breast Needle Aspiration | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer Therapy | Cardiology | Cardiovascular | Cholesterol | Chronic Kidney Disease | Chronic Leukemia | Clinical Trials | Conferences | Dementia | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Disability | Economic Slowdown | Education | Emergency Medicine | Endocrinology | Fortamet | Gastroschisis Repair | Gene Therapy | Genetics | Geriatrics | Germ Cell Tumors | Health | Health Medicine & Bioethics Commentators | Heart | Heart Attack | Heart Disease | Heart Failure | Hormones | Hospital Management | Hypertension | Immunotherapy | Insulin | Laboratory Medicine | Leukemia | Liver | Lung Cancer | Lymphoma | Medical Tourism | Men | Metformin | Mitochondria | Mitochondrial Disease | Neurology | Neuroscience | Nutrition | Obesity | Orthopaedics | Ovarian Cancer | Ovaries | Palliative | Palliative Care | Pancreas | Pancreatic Cancer | Parkinson's Disease | Pharmaceuticals | Politics | Profits and Losses | Research | Salaries | Science | Skin | Sports Medicine | Statistics | Stem Cell Therapy | Stem Cells | Stroke | Study | Teratoma | Toxicology | Training | Transplants | Universities & Medical Training | Urology & Nephrology | Venture Capital | Weight Loss